Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant FOLFIRI/XELIRI plus Avastin for unresectable colorectal liver metastases
2007-002105-44Phase 4Terminated
- Sponsor
- Military Medical Academy
- Start
- Jun 2008
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of bevacizumab, irinotecan, capecitabine, fluorouracil and folinic acid in colorectal cancer (CRC) (2 arms), sponsored by Military Medical Academy. Started Jun 2008; status: terminated.
02
Drugs
bevacizumabirinotecancapecitabinefluorouracilfolinic acid
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on 2007-002105-44.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-002105-44.